A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and ...

Degenerative joint diseases like osteoarthritis and intervertebral disk degeneration are conditions that affect millions of ...

SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025.

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), ...

The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis ...

Alithea Genomics has gained recognition for transforming RNA sequencing with its scalable and cost-effective solutions.

A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...

At a time when large-scale human genome analysis was not yet common, the Tohoku Medical Megabank Organization (ToMMo) ...